GR
GRI Bio, Inc.
GRI · NASDAQ
$1.81 -0.55% (-$0.01)
1M +6.43%
Market Cap $162.6K
P/E Ratio -
Div. Yield -
ROE 134.03%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.02x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 84.88%
ROIC 93.76%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 10.30x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
19 /100
Unstable Profitable years 0
Beta -0.66x
EPS volatility 169.48%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre GRI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
W. Marc Hertz
Employees
4
Headquarters
La Jolla
Evenimente viitoare
13 NOV.
Earnings
Upcoming earnings report